The discovery and development of GLP-1 receptor agonists for type 2 diabetes and obesity is a bench-to-bedside success story.1 Multiple GLP-1 receptor agonists are now in clinical use, such as ...

aSection of Musculoskeletal Disease, NIHR Leeds Musculoskeletal Biomedical Research Centre, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, ...

(5) For Figure 5B, it would be interesting if the authors could ... but the authors show that a chimeric FZD5CRD-FZD4 receptor can confer Wnt-dependent endocytosis to an otherwise endocytosis ...

Frizzled (FZD) proteins are the principal receptors of the Wnt signaling pathway ... p > 0.05), **** (p < 0.0001). Figure EV1. Characterization of the antibodies used for flow cytometry in this study.